Happy as a pig
Wednesday, 20 August, 2008
Preliminary reports from the trial of Imugene’s [ASX: IMU] Porcine Reproductive and Respiratory Syndrome [PRRS] vaccine have contained some promising results.
Pigs which had been administered the vaccine showed much lower levels of lung lesions than the control group.
Furthermore, the results appear to show that both administration methods tested – oral and injection – had similar effects.
PRRS slows weight gain in infected pigs. While the injection method resulted in slightly lower lesion levels, pigs administered the vaccine orally showed higher levels of weight gain.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
